Skin Allografting Activates Anti-tumor Immunity and Suppresses Growth of Colon Cancer in Mice.

CONCLUSIONS: Allogenic skin transplantation suppresses the tumor growth through activating the allogenic immune response, and it may provide a new immunotherapy option for the clinical refractory tumor treatment.
PMID: 29793087 [PubMed - as supplied by publisher]

Source: Translational Oncology - May 21, 2018 Category: Cancer & Oncology Authors: Li X, Lan X, Wang G, Liu Y, Zhao K, Lu SZ, Xu XX, Shi GG, Ye K, Zhang BR, Zhao YM, Han HQ, Du CG, Ichim TE, Wang H Tags: Transl Oncol Source Type: research